Last updated 2026-08-29
- Raised $8M Series A led by Avigdor Orlinsky, Apr 2022
- Raised $1.9M grant led by Gates Foundation, Jun 2026
- Raised $2M Series B led by Innovation Lab, Dec 2024
Total raised
$11.9M
Stage
—
Founded
2024
Headcount
—
HQ
Tel Aviv, Israel
Sector
Biotechnology
About
SalivaSense Diagnostics is an Israeli startup focused on developing non-invasive, cost-effective, and user-friendly saliva-based diagnostic tests. The company aims to provide reliable alternatives to traditional blood, urine, or tissue sample diagnostics for a wide range of diseases, including pregnancy, infectious diseases, and cancer. They have developed patented technology to overcome challenges associated with saliva's low biomarker concentration and inhibitory agents, making saliva a viable diagnostic medium. Their products include Salistick, a saliva-based pregnancy test, and they are working on tests for oral cavity cancer and other conditions.
Funding history · 3 rounds · $11.9M total
3 events/rounds · $11.9M Total Funding: $10.0M in Private Equity
Jun 2026
★ Gates Foundation
Dec 2024
★ Innovation Lab★ Charlottesville Angel NetworkabCDe
Apr 2022
Offices
Tel Aviv, Israel · HQ / main office
Q&A
- What is SalivaSense Diagnostics' primary focus?
- SalivaSense Diagnostics is a medical technology company focused on developing diagnostic solutions using saliva biomarkers, with a primary focus on improving blood cancer detection.
- When was SalivaSense Diagnostics founded?
- SalivaSense Diagnostics was founded in 2024.
- Where is SalivaSense Diagnostics headquartered?
- SalivaSense Diagnostics is headquartered in Tel Aviv, Israel.
- Who is the CEO and Founder of SalivaSense Diagnostics?
- Prof. Stella Liberman-Aronov is the CEO and Founder of SalivaSense Diagnostics, appointed in 2024.
- What sector does SalivaSense Diagnostics operate in?
- SalivaSense Diagnostics operates in the Medical Devices sector.
- What specific sub-sectors does SalivaSense Diagnostics target?
- SalivaSense Diagnostics targets the Diagnostics and Oncology sub-sectors.
- What is SalivaSense Diagnostics' core technology?
- SalivaSense Diagnostics' core technology involves the use of Saliva Biomarkers.
- Who are SalivaSense Diagnostics' target customers?
- SalivaSense Diagnostics' target customers are Oncologists.
Team · 6
Aaron Palmon
Founder · Co-Founder, President
Omer Deutsch
Founder · Co-Founder, CEO
Guy Krief
Founder · Co-Founder, Deputy CEO
Raluca Cohen
Founder · Co-Founder, CSO
Yoav Neumann
Founder · Co-Founder, Senior Scientist
Aviram Kenan
Commercial Development Manager
Sectors & technology
Primary sector
Biotechnology
Technologies
Target customers
Business model
B2CB2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2024 |
|---|